Business Context and Reporting Period
This Form 6-K filing by Nano Dimension Ltd. covers the month of February 2021, specifically reporting on a capital raise event announced on February 15, 2021. The company, headquartered in Ness Ziona, Israel, is a foreign private issuer filing under Rule 13a-16.
Key Financial Metrics
The filing details a registered direct offering with the following financial parameters:
- Gross Proceeds: Approximately $500.5 million.
- Shares Issued: 39,100,000 American Depositary Shares (ADSs).
- Offering Price: $12.80 per ADS.
- Placement Fee: 3% of gross proceeds payable to ThinkEquity (Fordham Financial Management, Inc.).
The filing does not provide data on revenue, profit, operating cash flow, margins, existing debt levels, or liquidity ratios as this document focuses solely on the pricing of the securities offering.
Material Changes
The primary material change is the agreement to issue 39,100,000 new ADSs, which will increase the company's share count and capital base upon closing. The company has agreed to a 30-day lock-up period following the closing, during which it will not issue or announce the issuance of additional ADSs, ordinary shares, or equivalents, subject to customary exceptions.
Guidance, Outlook, and Risks
Outlook and Timing: The closing of the sale is expected to occur on or about February 18, 2021, subject to customary closing conditions. The offering is being conducted pursuant to a prospectus supplement filed under a shelf registration statement (Form F-3).
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Actual results may differ due to market conditions and the satisfaction of closing conditions. The document references risk factors detailed in the company's annual report on Form 20-F filed on March 10, 2020.
Investor Verification Checklist
- Verify the final closing date of the offering (expected February 18, 2021) and confirmation of fund receipt.
- Review the full text of the Placement Agency Agreement (Exhibit 10.1) for additional fee structures or conditions.
- Confirm the updated share count and dilution impact post-closing.
- Examine the referenced Form 20-F (March 10, 2020) for comprehensive risk factors not detailed in this summary.